Product NDC: | 42858-302 |
Proprietary Name: | Hydromorphone Hydrochloride |
Non Proprietary Name: | Hydromorphone Hydrochloride |
Active Ingredient(s): | 4 mg/1 & nbsp; Hydromorphone Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42858-302 |
Labeler Name: | Rhodes Pharmaceuticals L.P. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019892 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20091123 |
Package NDC: | 42858-302-25 |
Package Description: | 100 TABLET in 1 BOX, UNIT-DOSE (42858-302-25) |
NDC Code | 42858-302-25 |
Proprietary Name | Hydromorphone Hydrochloride |
Package Description | 100 TABLET in 1 BOX, UNIT-DOSE (42858-302-25) |
Product NDC | 42858-302 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Hydromorphone Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091123 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Rhodes Pharmaceuticals L.P. |
Substance Name | HYDROMORPHONE HYDROCHLORIDE |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |